An Urgent Call for Environmental Accountability in Nephrology Clinical Trials
Overview
Overview
Journal
Clin Kidney J
Publisher
Oxford University Press
Specialty
Nephrology
Date
2024 Aug 5
PMID
39099570
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Mackillop N, Shah J, Collins M, Costelloe T, Ohman D
. Carbon footprint of industry-sponsored late-stage clinical trials. BMJ Open. 2023; 13(8):e072491.
PMC: 10445340.
DOI: 10.1136/bmjopen-2023-072491.
View
2.
Griffiths J, Fox L, Williamson P
. Quantifying the carbon footprint of clinical trials: guidance development and case studies. BMJ Open. 2024; 14(1):e075755.
PMC: 10823997.
DOI: 10.1136/bmjopen-2023-075755.
View
3.
Kotwal S, Perkovic V, Heerspink H
. Platform Clinical Trials Within Nephrology-Interpreting the Evidence. Am J Kidney Dis. 2022; 80(1):143-146.
DOI: 10.1053/j.ajkd.2022.01.430.
View
4.
Askin S, Burkhalter D, Calado G, El Dakrouni S
. Artificial Intelligence Applied to clinical trials: opportunities and challenges. Health Technol (Berl). 2023; 13(2):203-213.
PMC: 9974218.
DOI: 10.1007/s12553-023-00738-2.
View
5.
Adshead F, Salman R, Aumonier S, Collins M, Hood K, McNamara C
. A strategy to reduce the carbon footprint of clinical trials. Lancet. 2021; 398(10297):281-282.
DOI: 10.1016/S0140-6736(21)01384-2.
View